These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 7895227)
1. Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II. Cargill RI; Struthers AD; Lipworth BJ Cardiovasc Res; 1995 Jan; 29(1):108-11. PubMed ID: 7895227 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man. Cargill RI; Struthers AD; Lipworth BJ Clin Sci (Lond); 1995 Jan; 88(1):81-6. PubMed ID: 7705006 [TBL] [Abstract][Full Text] [Related]
3. C-type natriuretic peptide in chronic renal failure and its action in humans. Igaki T; Itoh H; Suga S; Hama N; Ogawa Y; Komatsu Y; Mukoyama M; Sugawara A; Yoshimasa T; Tanaka I; Nakao K Kidney Int Suppl; 1996 Jun; 55():S144-7. PubMed ID: 8743538 [TBL] [Abstract][Full Text] [Related]
4. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake. Carey RM; Vaughan ED; Peach MJ; Ayers CR J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631 [TBL] [Abstract][Full Text] [Related]
5. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats. Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815 [TBL] [Abstract][Full Text] [Related]
6. Bioactivity and metabolism of C-type natriuretic peptide in normal man. Hunt PJ; Richards AM; Espiner EA; Nicholls MG; Yandle TG J Clin Endocrinol Metab; 1994 Jun; 78(6):1428-35. PubMed ID: 8200946 [TBL] [Abstract][Full Text] [Related]
7. Effect of human atrial natriuretic peptide on angiotensin II-induced secretion of aldosterone in man. Vierhapper H Klin Wochenschr; 1986; 64 Suppl 6():50-2. PubMed ID: 2948063 [TBL] [Abstract][Full Text] [Related]
8. The effects of angiotensin II on circulating levels of natriuretic peptides. Cargill RI; Coutie WJ; Lipworth BJ Br J Clin Pharmacol; 1994 Aug; 38(2):139-42. PubMed ID: 7981014 [TBL] [Abstract][Full Text] [Related]
9. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man. Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056 [TBL] [Abstract][Full Text] [Related]
10. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system. Atlas SA; Volpe M; Sosa RE; Laragh JH; Camargo MJ; Maack T Fed Proc; 1986 Jun; 45(7):2115-21. PubMed ID: 2940120 [TBL] [Abstract][Full Text] [Related]
11. Renal interstitial hydrostatic pressure and natriuretic response to high doses of angiotensin II in pregnant rats. Yu T; Khraibi AA Am J Hypertens; 2006 Mar; 19(3):300-5. PubMed ID: 16500518 [TBL] [Abstract][Full Text] [Related]
12. Differing thresholds for modulatory effects of adrenomedullin infusion on haemodynamic and hormone responses to angiotensin II and adrenocorticotrophic hormone in healthy volunteers. Troughton RW; Frampton CM; Lewis LK; Yandle TG; Richards AM; Nicholls MG Clin Sci (Lond); 2001 Jul; 101(1):103-9. PubMed ID: 11410122 [TBL] [Abstract][Full Text] [Related]
13. The effects of angiotensin-II on lipolysis in humans. Townsend RR Metabolism; 2001 Apr; 50(4):468-72. PubMed ID: 11288044 [TBL] [Abstract][Full Text] [Related]
14. Effects of synthetic atrial natriuretic factor (ANF) on renin-aldosterone axis in the conscious newborn calf. Amadieu M; Giry J; Barlet JP J Dev Physiol; 1989 Jan; 11(1):15-8. PubMed ID: 2529306 [TBL] [Abstract][Full Text] [Related]
15. Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system. Gammelgaard I; Wamberg S; Bie P Acta Physiol (Oxf); 2006 Oct; 188(2):129-38. PubMed ID: 16948800 [TBL] [Abstract][Full Text] [Related]
16. Effects of acute mild hypercalcemia or of the calcium antagonist nifedipine on cardiovascular responsiveness to norepinephrine or angiotensin II in normal humans. Beretta-Piccoli C; Bianchetti MG; Weidmann P; Boehringer K; Link L; Morton JJ J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S306-12. PubMed ID: 6184559 [TBL] [Abstract][Full Text] [Related]
17. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart. Bauer WR; Neubauer S; Obitz G; Ertl G J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humans. Cargill RI; Lipworth BJ Thorax; 1995 Feb; 50(2):183-5. PubMed ID: 7701460 [TBL] [Abstract][Full Text] [Related]
19. [Effects of angiotensin II on inflammation mediators in healthy subjects]. Lottermoser K; Ulrich-Merzenich G; Vetter H; Düsing R Dtsch Med Wochenschr; 2003 Nov; 128(47):2470-5. PubMed ID: 14628252 [TBL] [Abstract][Full Text] [Related]
20. Haemodynamic and endocrine effects of digitoxin in healthy volunteers. Lucena MI; Moreno A; Garcia del Rio C; Bolaños MJ; Andrade R Int J Clin Pharmacol Res; 1987; 7(2):135-40. PubMed ID: 3294618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]